Cargando…

Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer

Myeloid derived suppressor cells (MDSC) are very important in tumor immune evasion and they dramatically increased in peripheral blood of patients with osteosarcoma cancer. The association between MDSC and various cytokines has been studied in the peripheral blood. However, little is known about the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Ying, Zhang, Rui, Peng, Zhibin, Dong, Daming, Wei, Guojun, Wang, Yansong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715437/ https://www.ncbi.nlm.nih.gov/pubmed/29226090 http://dx.doi.org/10.1016/j.jbo.2017.10.002

Ejemplares similares

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
por: Grauers Wiktorin, Hanna, et al.
Publicado: (2018)

Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma
por: Zhang, Jingzhe, et al.
Publicado: (2019)

The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients
por: Feng, Jiuxing, et al.
Publicado: (2020)

IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
por: Tobin, Richard P., et al.
Publicado: (2019)

Estrogens drive myeloid-derived suppressor cell accumulation
por: Conejo-Garcia, Jose R., et al.
Publicado: (2017)

miR-328-3p mediates the anti-tumor effect in osteosarcoma via directly targeting MMP-16
por: Shi, Jianhui, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy
por: Tomela, Katarzyna, et al.
Publicado: (2023)

Epigenetic modifications in the accumulation and function of myeloid-derived suppressor cells
por: Xu, Liangjie, et al.
Publicado: (2022)

Chrysin targets myeloid‐derived suppressor cells and enhances tumour response to anti‐PD‐1 immunotherapy
por: Li, Yinan, et al.
Publicado: (2022)

Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells
por: Garritson, Jacob, et al.
Publicado: (2020)

Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
por: Yang, Guoliang, et al.
Publicado: (2017)

Myeloid-derived suppressor cells (MDSCs): what do we currently know about the effect they have against anti-PD-1/PD-L1 therapies?
por: Tellez, Ronald Sergio Limón, et al.
Publicado: (2023)

Chronic Psychological Stress Induces the Accumulation of Myeloid-Derived Suppressor Cells in Mice
por: Jin, Jianfeng, et al.
Publicado: (2013)

Correlation of IL-18 with Tryptase in Atopic Asthma and Induction of Mast Cell Accumulation by IL-18
por: Wang, Junling, et al.
Publicado: (2016)

Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers
por: Tang, Yao, et al.
Publicado: (2022)

Specific inhibition of PI3Kδ/γ enhances the efficacy of anti-PD1 against osteosarcoma cancer
por: Shi, Xinge, et al.
Publicado: (2018)

ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells
por: Wang, Mingjin, et al.
Publicado: (2023)

Targeting myeloid-derived suppressor cells to attenuate vasculogenic mimicry and synergistically enhance the anti-tumor effect of PD-1 inhibitor
por: Li, Yinan, et al.
Publicado: (2021)

Targeting myeloid-derived suppressor cells to attenuate vasculogenic mimicry and synergistically enhance the anti-tumor effect of PD-1 inhibitor
por: Li, Yinan, et al.
Publicado: (2022)

Overexpression of miR-20a promotes the progression of osteosarcoma by directly targeting QKI2
por: Yang, Hongbo, et al.
Publicado: (2019)

Myeloid-derived suppressor cells control B cell accumulation in the CNS during autoimmunity
por: Knier, Benjamin, et al.
Publicado: (2018)

MicroRNA-503 Acts as a Tumor Suppressor in Osteosarcoma by Targeting L1CAM
por: Chong, Yang, et al.
Publicado: (2014)

Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance
por: Ajith, Ashwin, et al.
Publicado: (2023)

Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
por: Forghani, Parvin, et al.
Publicado: (2014)

Downregulation of CD40 expression contributes to the accumulation of myeloid-derived suppressor cells in gastric tumors
por: SHEN, JIN, et al.
Publicado: (2014)

Circadian Rhythm Disruption Increases Tumor Growth Rate and Accumulation of Myeloid-Derived Suppressor Cells
por: Roberts, Nathan T., et al.
Publicado: (2022)

Analysis of the Expression and Regulation of PD-1 Protein on the Surface of Myeloid-Derived Suppressor Cells (MDSCs)
por: Nam, Sorim, et al.
Publicado: (2019)

IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia
por: Fiordi, Benedetta, et al.
Publicado: (2023)

Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors
por: Zhang, Mengqi, et al.
Publicado: (2022)

Radiation and anti-PD-L1 antibody combinatorial therapy induces T cell-mediated depletion of myeloid-derived suppressor cells and tumor regression
por: Deng, Liufu, et al.
Publicado: (2014)

Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer
por: Youn, Je-In, et al.
Publicado: (2020)

Autophagy is positively associated with the accumulation of myeloid-derived suppressor cells in 4-nitroquinoline-1-oxide-induced oral cancer
por: Wu, Jia-Shun, et al.
Publicado: (2018)

Auranofin is a potent suppressor of osteosarcoma metastasis
por: Topkas, Eleni, et al.
Publicado: (2015)

Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin
por: Suk Lee, Young, et al.
Publicado: (2019)

The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia
por: Jimbu, Laura, et al.
Publicado: (2021)

Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
por: Lesokhin, Alexander M., et al.
Publicado: (2013)

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
por: Amaro, Adriana, et al.
Publicado: (2023)

Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
por: Subhash, Vinod Vijay, et al.
Publicado: (2018)

IL-12 Enhances Immune Response by Modulation of Myeloid Derived Suppressor Cells in Tumor Microenvironment
por: Choi, Ji-Na, et al.
Publicado: (2019)

Myeloid-derived suppressor cells and vaccination against pathogens
por: Prochetto, Estefanía, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j55e3hdim2038fv0botbraj22k